--- title: "MIRA Pharmaceuticals 的股價飆升,因為其口服止痛藥在動物研究中表現優於嗎啡" description: "MIRA Pharmaceuticals 的股票在盤前交易中上漲了 90%,達到 2.52 美元,此前其口服藥物 Mira-55 在一項針對慢性炎症性疼痛的動物研究中表現優於嗎啡。該藥物通過靶向 CB2 受體有效地使疼痛水平正常化並減少炎症,而嗎啡僅部分緩解了炎症。這一積極的數據支持了 MIRA 對 Mira-55 進行市場申請的計劃。今年迄今為止,股票已上漲約 16%" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/261424289.md" published_at: "2025-10-16T11:08:49.000Z" --- # MIRA Pharmaceuticals 的股價飆升,因為其口服止痛藥在動物研究中表現優於嗎啡 > MIRA Pharmaceuticals 的股票在盤前交易中上漲了 90%,達到 2.52 美元,此前其口服藥物 Mira-55 在一項針對慢性炎症性疼痛的動物研究中表現優於嗎啡。該藥物通過靶向 CB2 受體有效地使疼痛水平正常化並減少炎症,而嗎啡僅部分緩解了炎症。這一積極的數據支持了 MIRA 對 Mira-55 進行市場申請的計劃。今年迄今為止,股票已上漲約 16% 藥物開發公司 MIRA Pharmaceuticals (MIRA.O) 的股價在盤前上漲 90%,至 2.52 美元 公司表示,其實驗性口服藥物 Mira-55 在一項針對慢性炎症性疼痛的臨牀前動物研究中,緩解疼痛和減少腫脹的效果優於注射嗎啡 Mira-55 將疼痛水平恢復到正常,並通過靶向 CB2 受體直接減少炎症 - MIRA CB2 受體在免疫細胞中表達,參與免疫反應和炎症的調節 公司表示嗎啡僅部分減少了炎症 數據支持 Mira-55 用於慢性炎症性疼痛的市場申請計劃 - MIRA 截至上一個收盤,股價年初至今上漲約 16% ### Related Stocks - [MIRA.US - Mira Pharmaceuticals](https://longbridge.com/zh-HK/quote/MIRA.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Mira Pharmaceuticals' Oral Mira-55 Outperforms Morphine in Pain Relief and Inflammation Reduction, Preclinical Study Shows | Mira Pharmaceuticals Inc. announced preclinical results showing that its oral marijuana analog, Mira-55, outperformed mo | [Link](https://longbridge.com/zh-HK/news/261314660.md) | | Even Elephants Have Enemies: 8 Animals That Can Take Them Down | The article discusses the surprising fact that elephants, despite being the largest land animals, can have predators. It | [Link](https://longbridge.com/zh-HK/news/276250634.md) | | China’s Bio-Thera Gets EU’s Marketing Approval for Its Inflammatory Autoimmune Disease Drug | China’s Bio-Thera Solutions has received EU marketing approval for its drug Gotenfia (golimumab injection), aimed at tre | [Link](https://longbridge.com/zh-HK/news/275867563.md) | | Tractor Supply Announces a Flock of Animal-Friendly Festivities Launching This Month \| TSCO Stock News | Tractor Supply Company (NASDAQ: TSCO) is launching a series of animal-focused events in February, including Chick Days a | [Link](https://longbridge.com/zh-HK/news/276063929.md) | | 16:47 ETPet Partners Nominations Open for 2026 Pet of the Year, Celebrating the Moments Pets Change Lives | Pet Partners has opened nominations for the 2026 Pet of the Year fundraiser, inviting pet lovers to recognize pets that | [Link](https://longbridge.com/zh-HK/news/276173667.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。